Brian J Pontius, MPAS PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 4095 E Pony Express Pkwy, Eagle Mountain, UT 84005 Phone: 801-429-8037 |
Cami Jo Watt, PA-C Physician Assistant - Medical Medicare: Not Enrolled in Medicare Practice Location: 3943 E Pony Express Pkwy Ste 120, Eagle Mountain, UT 84005 Phone: 801-789-5566 |
Angela Salveson, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 4095 E Pony Express Pkwy Ste 1, Eagle Mountain, UT 84005 Phone: 801-429-8037 Fax: 801-753-7476 |
Cherokee Carrillo, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 4095 E Pony Express Parkway, Eagle Mountain, UT 84005 Phone: 801-429-8037 Fax: 801-753-7476 |
Ms. Elizabeth A Pritt, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 4095 E Pony Express Parkway, Suite 1, Eagle Mountain, UT 84005 Phone: 801-429-8037 Fax: 801-753-7476 |
Mr. Jay Cannon Lambert, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 4095 E Pony Express Pkwy, Ste 1, Eagle Mountain, UT 84005 Phone: 801-429-8037 Fax: 801-753-7476 |
Logan Kupitz, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 4095 E Pony Express Pkwy Ste 1, Eagle Mountain, UT 84005 Phone: 801-429-8037 |
Stacie Helene Jones, PA-C Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 4095 E Pony Express Pkwy Ste 1, Eagle Mountain, UT 84005 Phone: 801-429-8037 Fax: 801-418-0941 |
News Archive
Aerobic exercise training restored the cardiac protein quality control system in rats showed a study recently published in Journal of Cellular and Molecular Medicine.
Based on a review of the latest evidence, the Guidelines Committee of the Heart Failure Society of America now recommends that the use of cardiac resynchronization therapy (CRT) be expanded to a larger group of patients with mild heart failure symptoms.
Cancer Research Technology Limited (CRT), the oncology-focused development and commercialisation company, and The University of Manchester have entered into an agreement with AstraZeneca to establish a clinical pharmacology biomarker research and discovery collaboration.
Enrollment has begun in an early-stage clinical trial testing the safety of two human monoclonal antibodies (mAbs) designed to treat people infected with Middle East respiratory syndrome coronavirus (MERS-CoV).
› Verified 7 days ago